Chondrosarcoma - 22 Studies Found

Active, not recruiting : Proton Beam Therapy for Chondrosarcoma
: Chondrosarcoma
: 2007-07-02
: Procedure: Proton Beam Therapy A total dose of up to 70 CGE given at 2.0 CGE per daily fraction for 35 f
Recruiting : Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base
: Chondrosarcoma
: 2010-08-12
:
  • Radiation: carbon ion therapy

Active, not recruiting : Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
:
  • Chondrosarcoma
  • Metastatic Chondrosarcoma<
    : 2011-04-06
    : Drug: pazopanib Pazopanib 800 mg orally once daily will be started on Cycle 1 Day 1 and will be administ
Suspended : A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
: Chondrosarcoma
: 2013-12-06
:
  • Drug: Everolimus 2.5 mg/day Co
Terminated : A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
: Chondrosarcoma
: 2007-10-12
: Drug: PRO95780 Intravenous repeating dose
Completed : A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
: Conventional Chondrosarcoma
: 2011-03-03
:
  • Drug: IPI-926 Oral
Completed : Proton Therapy for Chordomas and/or Chondrosarcomas
:
  • Chordomas
  • Chondrosarcomas

: 2008-11-24
Recruiting : Proton Radiation for Chordomas and Chondrosarcomas
:
  • Chordomas
  • Chondrosarcomas

: 2011-10-04
: Radiation: Proton Therapy
Recruiting : Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
:
  • Chordoma
  • Chondrosarcoma

: 2007-12-28
: Radiation: Charged Particle Radiation Therapy Radiation doses will be determined by planning CT
Active, not recruiting : Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
:
  • Advanced Desmoid Tumor
  • Advanced Chondrosarcoma

: 2009-06-25
: Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months
Next >>>